About This 510(k) Submission
K152875 is an FDA 510(k) clearance for the QUANTA Flash B2GP1-Domain1, QUANTA Flash B2GP1-Domain1 Controls, HemosIL AcuStar Anti-B2GPI Domain 1, HemosIL AcuStar Anti-B2GPI Domain 1 Controls, a System,test,antibodies,b2 - Glycoprotein I (b2 - Gpi) (Class II — Special Controls, product code MSV), submitted by Inova Diagnostics, Inc. (San Diego, US). The FDA issued a Cleared decision on December 21, 2015, 82 days after receiving the submission on September 30, 2015. This device falls under the Immunology review panel. Regulated under 21 CFR 866.5660.